| Dienstag | 07:30 - 12:00 Uhr |
| 12:45 - 17:30 Uhr | |
| Mittwoch | 07:30 - 12:00 Uhr |
| 12:45 - 14:30 Uhr | |
| Donnerstag | 07:30 - 12:00 Uhr |
| 12:45 - 17:30 Uhr | |
| Freitag | 07:30 - 12:00 Uhr |
| 12:45 - 14:30 Uhr |
Sie finden die Gastroenterologie im Haupthaus, C2 (roter Bereich), Erdgeschoss.
Leistungen im Detail
- Angeboten werden alle zugelassenen Therapieverfahren inklusive aller verfügbaren Antikörpertherapien
- Enge Kooperation mit stationärer Versorgung und Hausärzten
- Interdisziplinäre Fallbesprechung
- Durchführung komplexer Behandlungsverfahren möglich
Publikationen und Studien
- Helicobacter pylori (Hp) infection and upper gastrointestinal mucosal changes in Crohn's disease patients from the population with high prevalence of Hp. Y Marakhouski, T Staliarova, J Gorgun, S Beliauskaya, V Stahievich at al. Japan Journal of Research 2023. 2 (1).
- Over-expression of ΒII-tubulin and especially its localization in cell nuclei correlates with poorer outcomes in colorectal cancer. K Ruksha, A Mezheyeuski, A Nerovnya, T Bich, G Tur, J Gorgun at al. Cells 2019. 8 (1), 25.
- Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer. A Mezheyeuski, C Strell, I Hrynchyk, TK Guren, A Dragomir at al. Virchows Archiv 2018. 472, 395-405.
- Pathogenetic treatment of gastritis as a basis for the prevention of gastric cancer in the countries of the commonwealth of independent states: literature review and the Resolution of a Scientific Symposium Held in Minsk, Republic of Belarus, January, 27, 2018. VT Ivashkin, IV Maev, JV Gorgun, KS Kaliaskarova, MM Karimov at al. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2018 28 (4), 7-14.
- Over‐Expression of the β II Isotype of Tubulin and Especially Its Localization in Cell Nuclei Correlates with Poorer Outcomes in Colorectal Cancer. K Ruksha, A Mezheyeuski, A Nerovnya, T Bich, G Tur, J Gorgun et al. Molecular Biology of the Cell 2017, 28 (26), 3727-3727.
- Inflammatory Bowel Diseases (IBD) are associated with changes in beta1-tubulin expression epithelial cells. A Portyanko, P Perevoschikov, K Ruksha, J Gorgun. Virchows Archiv 2016. 469 (SUPPL 1), S159-S159.
- Inflammatory bowel disease is associated with cytoskeleton rearrangement in the epithelial cells. A Portyanko, P Perevoschikov, K Ruksha, J Gorgun. Journal Of Crohns & Colitis 2016. 10, S102-S103.
- Expression Of Tyrosinated A-Tubulin In Crohn's Disease. P Peravoshchykau, A Portyanko, J Gorgun. Innovation development, 2016. 100-105.
- Expression of tyrosinated α-tubulin in Crohn’s disease and ulcerative colitis. P Peravoshchykau, A Portyanko, J Gorgun. 2016. International Student’s Journal of Medicine 2 (1), 25-30
- Celiac Disease after the Diagnosis: What We Expect and What Happens in the Reality. J Gorgun, A Portyanko. International Journal of Celiac Disease 2014. 2 (1), 31-32.
- βIII-tubulin at the invasive margin of colorectal cancer: possible link to invasion. A Portyanko, P Kovalev, J Gorgun, E Cherstvoy. Virchows Archiv 2009. 454, 541-548.
- Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study. J Gorgun, A Portyanko, Y Marakhouski, E Cherstvoy. Virchows Archiv 2009. 455, 363-373.
- Collagenous sprue: a case description. Gorgun JV. Klin Med (Mosk) 2007. 82 (2), 70-72.
- Expression of tissue transglutaminase in small intestine biopsy specimens in coeliac disease. I Kletskaya, AS Portaynko, JV Gorgun. European Journal Of Medical Research 2009. 14, 192-192.
- High grade tumour budding in colorectal cancer is associated with up-regulation of beta III-tubulin expression at the invasive margin A Portyanko, J Gorgun, P Kovalev at al. Virchows Archiv. 2009. 455, 46-47.
- Tissue transglutaminase over-expression in celiac duodenal mucosa is remarkable but not specific for celiac disease. J Gorgun, A Portyanko, S Kuralenia. Virchows Archiv 2009. 455, 126-127.
- Prevalence of coeliac autoimmunity among persons with type 1 diabetes in Belarus. D Garmaev, N Karlovich, O Sysoeva, J Makarova, J Gorgun at al. Hormone Research. 2006. 65, 55-56.
- Certolizumab-Pegol, Active Crohn’s disease, Phase III multinational, multicentre Study, 2004-2009, Study coordinator and investigator
- Mesalamin, Active Ulcerative Colitis (Phase III, multicentral, international Study), 2006-2007, Study coordinator and investigator)
- Mesalamin, Active Ulcerative Colitis: A Randomized Placebo‐Controlled Double‐Blind Study to Evaluate the Efficacy and Safety of Asacol™ 4.8 g/day (800 mg tablets) for the Treatment of Active Ulcerative Colitis, 2010, Study coordinator
- Mesalamin, A Randomized Placebo‐Controlled Double‐Blind Study to Evaluate the Efficacy and Safety of TP05 3.2 g/d for the Treatment of Active Ulcerative Colitis, 2015-2016, Study coordinator
- Ozanimod, RPC01-3101 True North Trial, A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis, 2016-2018, Study coordinator
- Ausbildung
- Berufliche Laufbahn
1989 - 1995 | Studium der Humanmedizin an der Belarussischen Staatlichen Medizinischen Universität, Minsk
2000 | Promotion im Klinischen Forschungsinstitut für Radiationsmedizin und Endokrinologie, Minsk, Belarus, Erwerben des Titels „Kandidat der medizinischen Wissenschaften“
2011 | Promotion in der Belarussischen Medizinischen Akademie für postgraduale Weiterbildung, Minsk, Dissertationsthema “Zöliakie bei Erwachsenen: Diagnostik, klinische und molekular-genetische Charakteristik“, Erwerben des Titels „Doktor der medizinischen Wissenschaften“
2003 | Fachkenntnisprüfung für Gastroenterologie, Minsk, Belarus
2001 - 2018 | Klinische Tätigkeit im Bereich Innere Medizin/Gastroenterologie im 1. und 10. Klinikum in Minsk, Lehrtätigkeit als Dozentin (seit 2005) auf dem Lehrstuhl für Gastroenterologie und Ernährung der Belarussischen Medizinischen Akademie für postgraduale Weiterbildung
2013 - 2018 | Leitung des Belarussischen Gastroenterologischen Zentrums mit Schwerpunkt CED
2018 | Deutsche Approbation als Ärztin (Land Brandenburg)
2018 - 2021 | Facharztausbildung Innere Medizin und Gastroenterologie, Oberhavel Kliniken GmbH, Oranienburg
2021 | Prüfung zum Facharzt für Innere Medizin und Gastroenterologie (Land Brandenburg)
2021 - 2022 | Oberärztin auf der internistischen Station, Oberhavel Klinik Gransee
Seit 03/2023 | Ambulante Gastroenterologin an der Poliklinik des Helios-Klinikums Berlin-Buch (Klinikum der Maximalversorgung)